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Abstract: In the last years it has become increasingly clear that the mammalian 
transcriptome is highly complex and includes a large number of small non-coding RNAs 
(sncRNAs) and long noncoding RNAs (lncRNAs). Here we review the biogenesis 
pathways of the three classes of sncRNAs, namely short interfering RNAs (siRNAs), 
microRNAs (miRNAs) and PIWI-interacting RNAs (piRNAs). These ncRNAs have been 
extensively studied and are involved in pathways leading to specific gene silencing and the 
protection of genomes against virus and transposons, for example. Also, lncRNAs have 
emerged as pivotal molecules for the transcriptional and post-transcriptional regulation of 
gene expression which is supported by their tissue-specific expression patterns, subcellular 
distribution, and developmental regulation. Therefore, we also focus our attention on their 
role in differentiation and development. SncRNAs and lncRNAs play critical roles in 
defining DNA methylation patterns, as well as chromatin remodeling thus having a 
substantial effect in epigenetics. The identification of some overlaps in their biogenesis 
pathways and functional roles raises the hypothesis that these molecules play concerted 
functions in vivo, creating complex regulatory networks where cooperation with regulatory 
proteins is necessary. We also highlighted the implications of biogenesis and gene 
expression deregulation of sncRNAs and lncRNAs in human diseases like cancer. 
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1.1. The Incredible RNA Molecules 
RNA has been known since the late 1800s, but its importance in cell functioning has long been in 
the shadow of DNA and proteins. In the 1950s, with the establishment of the molecular structure of 
DNA, it was proposed that RNA would be an intermediate molecule in the information flux between 
DNA and proteins. Later, this was experimentally demonstrated revealing that during gene expression, 
DNA is copied in a molecule of messenger RNA (mRNA) that is then translated into proteins with the 
help of other RNA molecules like transfer RNA (tRNA) and ribosomal RNAs (rRNAs). The idea that 
RNAs are much more than molecules involved in storage/transfer of information emerged with the 
discovery of ribozymes, RNA molecules that have, like proteins, active roles as catalysts of chemical 
reactions in cells. The two ribozymes identified first have RNAs as substrates and were the 
Tetrahymena intron of the 26S rRNA that is a self-sufficient catalytic unit capable of autoexcision  
and autocyclization [1], and the ribonucleoprotein, RNase P, an enzyme containing an RNA subunit 
essential for the catalysis required for the synthesis of tRNAs [2]. These discoveries clearly 
encouraged a variety of studies to search for potential new roles of RNA molecules in vivo, and led to 
the re-evaluation of RNAs as crucial molecules in the evolution of life. In view of the ability of RNAs to 
catalyze biological reactions, it is conceivable that the first organisms could rely only on RNA molecules 
and that only later an evolution of a more complex system based on proteins was established. This 
hypothesis gave support to the model of a primordial “RNA World” (for review [3,4]). 
Progressively, the participation of RNAs in other critical molecular processes in eukaryotic cells 
was revealed, as in the case of DNA replication (RNA primers allow DNA polymerases to start the 
process), protein translation and RNA transcript maturation. For example, several ribosome functions 
required for protein synthesis were shown to be, at least in part, RNA-mediated, including peptidyl 
transferase activity [5], decoding functions [6], and the tRNA acceptor site interaction with 23S rRNA [7]. 
On the other hand, many small non-coding RNA molecules were isolated and characterized as being 
associated with proteins originating from ribonucleoprotein complexes (RNP), later identified as the 
components of the splicesome, including U1, U2, U4, U5 and U6 small nuclear RNA (snRNA) [8].  
Furthermore, the information content of tRNA, rRNA and mRNA molecules can be biochemically 
altered after transcription by different molecular mechanisms that are generally designated by RNA 
editing [9]. These include sequence changes such as nucleoside modifications from C to U and A to I 
deaminations, as well as non-templated nucleotide additions and insertions. In general, RNA editing 
mechanisms are based on protein or protein-RNA complexes responsible for the RNA editing reaction 
and require a “guide RNA” molecule, which, through base-pairing with the target RNA molecule, 
determines the editing site. By this mechanism an mRNA sequence may be post-transcriptionally 
altered and consequently the amino acid sequence of the protein will then differ from that predicted by 
the genomic DNA sequence. Moreover, post-transcriptional processing and modifications of rRNAs 
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are important for the production of efficient and accurate ribosomes which is directed by two large 
guide families of small nucleolar RNAs (snoRNA) [10]. 
In the mid-1980s Blackburn and Greider, demonstrated the existence of an enzymatic activity 
within cell extracts that added tandem hexanucleotides to chromosome ends and led to the discovery of 
telomerase [11]. Today it is well established that telomerase is a specialized reverse transcriptase that 
uses an internal RNA template sequence that is responsible for the synthesis of telomeric repeats [12]. 
More recently, Quiao and Cech [13] have described that the non-template RNA part of telomerase 
works together with the protein reverse-transcriptase motifs to facilitate catalysis, using a mechanism 
resembling that of pure ribozymes [13]. According to the “RNA first” model it was speculated that 
telomerase arose by the association of an ancient ribozyme with the reverse-transcriptase subunit. In 
light of this hypothesis the telomerase RNA may be a molecular fossil and telomerase a missing link in 
the evolution from RNA enzymes to protein enzymes [13]. This type of close functional collaboration 
is also observable in snoRNPs. 
At this point the growing descriptions of the importance of RNA molecules for cell function started 
to push them to the limelight, but the complexity of their roles and the wide variety of molecular 
mechanisms where RNA molecules are critical players was still far from clear. In recent years, the use 
of genome wide approaches and the large output of genome sequencing technologies have revealed 
that the mammalian transcriptome is much more complex than previously thought since it includes a 
large number of small non-coding RNAs (sncRNAs) and long noncoding RNAs (lncRNAs) [14,15]. In 
most cases, these molecules present complex and precise patterns of expression during differentiation 
and development, tissue specificity, and some have been related to different pathophysiological  
states [16]. For example, it became clear that snoRNA guide families are widely diverse, which seems 
to be related to variant snoRNA structures and multiple cellular RNA targets, and consequently to 
cellular functions beyond ribosome biogenesis [10,17]. Indeed, snoRNAs have been recently 
implicated in alternative splicing and in cell transformation, tumorigenesis, and metastasis (for review, 
see [18]) showing that we are far from having a complete picture of their roles in vivo. Importantly, the 
observations that exogenously introduced double stranded RNA (dsRNA) molecules and plasmids 
expressing short hair-pin RNA (shRNA) specifically base-pairing with target mRNA molecules were 
able to trigger mRNA degradation (RNA interference -RNAi) [19,20] revealed, for the first time, that 
specific silencing pathways based on sncRNAs operate in eukaryotic cells. Moreover, these 
observations led to the development of the powerful RNA interference (RNAi) technique that has been 
extensively used in the study of gene function. 
The aim of this review is to give a summarized overview of the biogenesis pathways of distinct 
classes of sncRNAs, including miRNA, piRNA, and siRNA, as well as lncRNAs, focusing on the 
miRNA and lncRNAs gene regulatory roles in distinct cellular functions and developmental regulatory 
programs. We will highlight the implications of the deregulation of miRNA and lncRNAs biogenesis 
pathways further illustrating the role of these molecules in the establishment of human diseases such as 
cancer. Finally, we will bring to discussion the fact that the pathways where distinct family members 
of sncRNAs and lncRNA funtion are probably interconnected, establishing a complex network of 
interactions and actions required for rapid and fine-tuned gene expression regulation at multiple levels.  
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1.2. The Small Non-Coding RNAs 
Three classes of sncRNAs, namely short interfering RNAs (siRNAs), microRNAs (miRNAs) and 
PIWI-interacting RNAs (piRNAs), have been extensively studied in the last decade and have been 
associated with pathways that lead to silencing of specific genes and to the protection of the 
cell/genome against viruses, mobile repetitive DNA sequences, retro-elements and transposons [16].  
1.2.1. siRNAs and miRNAs 
The siRNAs and miRNAs (~20–30 nucleotides long) originate from double-stranded RNA 
(dsRNA) precursors that are introduced into, or produced endogenously by gene transcription of both 
sense and anti-sense DNA strands and of pseudogenes and inverted repeats. These molecules are 
critical in pathways involved in mRNA degradation, translational repression, or both, therefore 
regulating gene expression.  
In the case of siRNAs, they are small RNA duplex molecules produced by the action of Dicer, a 
ribonuclease III (RNaseIII) enzyme that creates RNA duplexes with 2-nt overhangs at their 3' ends and 
phosphate groups at their 5' ends [21].  
The miRNAs are mostly transcribed by RNA polymerase II as primary-miRNA (pri-miRNA) 
molecule precursors that possess a characteristic stem loop structure and are subsequently subjected to 
processing mechanisms [22]. In animals, the first step occurs in the nucleus where the RNaseIII Drosha 
acts over pri-mRNAs generating a pre-miRNA, a small RNA duplex of ~65–70 nucleotides containing the 
hair pin. This action can be facilitated by RNA processing proteins such as hnRNP A1 [23]. The  
pre-miRNAs are then exported to the cytoplasm by a nuclear transport receptor complex,  
exportin-5–RanGTP [24] where they are processed by Dicer into ~22-nt mature miRNAs  
(miRNA–miRNA* duplexes, where miRNA is the antisense, or guide/mature strand, and miRNA* is 
the sense, or passenger strand). 
An alternative nuclear pathway for miRNA biogenesis was described in invertebrates [25] where 
the pre-miRNA is processed via splicing/spliceosome, instead of Drosha. Accordingly, spliced lariats 
linearized by the lariat debranching enzyme accept monophosphates and 3' hydroxyls, the same 
moieties found in pre-miRNAs, that were designated by-miRNAs/introns, “mirtrons” (for review [24]). 
These mirtrons are subsequently exported to the cytoplasm and processed by a Dicer protein. 
The next step, for both siRNA and miRNA production, is the subsequent association with members 
of the Argonaute protein family that have diverged into specialized clades (or subfamilies), each 
recognizing different sncRNA types and conferring the specific features of the various silencing 
pathways operating in cells [26]. Argonaute loading occurs in the RNA-induced silencing complex 
(RISC)-loading complex, a ternary complex that consists of an Argonaute protein, Dicer and a  
dsRNA-binding protein (known as TRBP in humans). During loading, the non-guide strand is cleaved 
by an Argonaute protein [22]. 
The selection of the different Argonaute proteins seems to be based on the small interfering RNA 
duplex structure. For example, siRNAs that are perfect duplexes in terms of base pairing are loaded 
into Argonaute 2 (Ago2), whereas duplexes presenting mismatches, as in the case of miRNAs, are 
generally driven to Argonaute 1 (Ago1) [27,28]. When the complementarity between the miRNA 
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bound to Ago1 and the target RNA is high, this causes miRNA tailing and 3'- to 5'-trimming. The 
discrimination between Ago1 and Ago2 seems to depend on the action of Hen1 an enzyme that adds 
the 2'-O-methyl group at the 3' ends of small RNAs bound to Ago2, but not those bound to Ago1 [29]. 
This methyl group is known to block tailing and trimming of the miRNA. The maturation and function 
of certain miRNAs can be also associated to enzymatic post-transcriptional modifications, like  
mono-uridylation [30]. These modifications will increase the variety of miRNAs and their precursor 
pools allowing more complex schemes of regulation in different backgrounds. 
In the small RNA duplex of the siRNA the guide strand seems to be the one whose 5' end is less 
tightly paired to its complement [31]. In both siRNAs and miRNAs the guide strands drives the RISCs 
to the target mRNAs that contain complementary sequences thereby causing their degradation or 
translation inhibition (for review [16,32]). Recently, it has been shown that the target choice can also 
depend on accessory factors that interact with Dicer. For example, the Drosophila Loqs-PB  
Dicer-partner cleaves pre-miR-307a, generating a longer miRNA isoform with a distinct seed sequence 
and target specificity [33]. The mammalian TRBP homologue also acts together with Dicer to cleave 
pre-miR-132 generating a longer miRNA and consequently targets different mRNA molecules [34]. 
In fission yeast a specialized nuclear complex, known as the RNA-induced transcriptional silencing 
complex (RITS), mediates transcriptional gene silencing by inducing heterochromatin formation [35]. 
The RITS complex consists of Chp1 (H3K9me binding protein), Ago1, a poorly characterized protein 
Tas3, and siRNAs derived from centromeric repeat sequences [36]. These studies also showed the 
existence of a tight coupling of both siRNA and H3K9 methylation that appears to be important for the 
recruitment of RITS for heterochromatin assembly [37]. Therefore, there seems to exist a complex 
interplay between the RNAi pathway and the chromatin modifying machinery [37]. 
1.2.2. The piRNAs 
The piRNAs are the least characterized class of sncRNAs and, contrary to the siRNAs and miRNAs 
that are widely expressed in different tissues and cell types, the piRNAs have been essentially detected 
in the germline cells of mammals, fish and Drosophila melanogaster [38,39] where they are important 
for germ line development and to suppress transposon activity. Mutations that disrupt the piRNA 
biogenesis pathway in mouse and fish cause germline-specific cell death and sterility, and are also 
associated with increased transposon expression [40]. 
The piRNAs (~24–31 nucleotides) got their name from the fact that they only associate to the PIWI 
subfamily of the Argonaute protein family (Piwi proteins). These sncRNAs usually have a uridine at 
the 5' end, hold a 5' monophosphate, and present a 2'-O-methyl (2'-O-Me) modification on the 
nucleotide at the 3' end (for review, see [32]).  
Although not much is known concerning the intervening factors involved in piRNAs biogenesis 
pathways and transcription regulation, it is now well documented that they diverge from siRNAs and 
miRNAs by being generated by RNaseIII-independent pathways that do not involve dsRNA 
precursors. These sncRNAs are generated from long single-stranded precursors [41,42] that are 
preferentially cleaved at U residues and loaded onto Piwi proteins.  
In Drosophila, as in mammals, the majority of piRNAs are transcribed from discrete genomic loci 
that are clustered in large pericentromeric or subtelomeric domains, generally spanning from  
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50–100 kb, and that comprise mainly various transposable DNA elements and their remnants [41]. 
Other piRNAs are derived from 3' UTRs of protein coding genes and dispersed euchromatin copies of 
transposable elements [41,43]. Most of these clusters are active specifically in germ cells, while only a 
single major cluster (flamenco) impels transposon silencing in the soma. Interestingly, if new 
transposons are introduced into piRNA clusters, and if they are heritable by the progeny, novel piRNAs 
will be produced that can lead to the control of the new transposons indicating that the mechanisms that 
drive adaptation to transposon invasion might be mediated by the piRNA pathway [44]. 
The critical role of piRNAs on transposon silencing was demonstrated by loss-of function mutations 
in Drosophila piRNAs and genes coding for the proteins involved in their biogenesis. In the  
germline these mutations cause a retro-transposition up-regulation causing the loss of germ cells and a 
variety of defects due to alterations in microtubule cytoskeleton polarization, with consequences to the 
polarized localization of specific proteins and mRNAs required for normal oogenesis [45]. However, it 
was found that the derepression of transposons activates the Chk2 DNA damage checkpoint [44] 
suggesting that the described phenotypes are probably an indirect consequence of transposon 
overexpression and DNA damage signaling (for review [44]).  
Other studies also reveal that besides being involved in keeping genome integrity, a subset of 
piRNA genes have been implicated in the assembly of the telomere protection complex [46].  
Detailed analysis of the small RNAs associated with the Piwi sub-family (PIWI, Aubergine and 
Argonaute 3) [41,47] in the Drosophila female germline showed that these sncRNAs have in their 
structure and sequences, signatures that give clues about their biogenesis. The most abundant piRNAs 
are mainly generated from the antisense strand of retro-transposons and these preferentially associate 
with Piwi and Aubergine proteins [41,47]. Those present in the single major somatic cluster are mainly 
originated from the sense strand and are associated with Argonaute 3 (Ago3). 
The piRNAs from the germ cells seem to be generated by a self-amplifying loop designated by 
ping-pong cycle. Specifically, PIWI and/or Aubergine form complexes with antisense piRNAs that 
direct the slicing of sense strand transposon transcripts [41,47]. The sliced sense strands are then bound 
by Ago3, and this complex directs the slicing of antisense transposon transcripts [41]. A similar 
mechanism seems to operate in other animal genomes [42,48]. The piRNAs derived from genomic 
regions depleted of transposons, seem to be generated by a different pathway not completely 
understood called “primary processing” that operates in somatic cells, and may have a role in the 
regulation of target mRNAs (for review [32]). 
Recent studies have shown that, in addition to their role in germ line transposon regulation and 
genome stability, piRNAs have a broader function in heterochromatin formation and developmental 
gene regulation. The analysis of a high-throughput small RNA sequencing data in Drosophila, mouse 
and rhesus macaque samples demonstrated that piRNAs are widespread and are abundant in other 
tissues as much as in the germline [49]. In fact, their involvement in the regulation of gene expression 
was demonstrated in Drosophila, where the degradation of a subset of maternal RNAs, i.e., embryonic 
posterior morphogen Nanos (Nos), at the maternal-to-zygotic transition, was shown to require the 
zygotic expression of a piRNA cluster [50]. When this expression is inhibited, the Nos mRNA is 
stabilized which was accompanied by a reduced deadenylation and translational derepression, resulting 
in head development defects. Because the piRNAs involved in this regulation are produced from 
Int. J. Mol. Sci. 2013, 14 16016 
 
 
transposable elements, the authors suggested the existence of a direct developmental function for 
transposable elements in the regulation of gene expression through piRNAs [50].  
The importance of the piRNAs pathway in the nervous system and in epigenetic regulation has also 
been gaining support. In the hippocampus, the inhibition of piRNAs causes a decrease of the dendrite 
spine area suggesting that these sncRNAs are required for spine morphogenesis [51]. More recently, in 
Aplysia sensory neurons, a Piwi/piRNA complex was described to facilitate the methylation of a 
conserved CpG island in the promoter of the transcriptional repressor of memory, CREB2, in a 
serotonin-dependent manner [52]. Consequently, this Piwi/piRNA complex is at the cross-roads 
between a transient external stimuli and alterations in the gene-expression of neurons involved in long 
term memory storage. Sienski et al. [53] have also shown that in Drosophila ovarian somatic cells 
piRNAs mediate the silencing of hundreds of transposon copies at the transcriptional level by 
establishing heterochromatic methylation of H3K9 on transposons and their genomic surroundings. 
The involvement of the piRNA pathway in de novo methylation of the differentially methylated region 
of the imprinted mouse Rasgrf1 locus [54] shows that the role of this pathway in methylation is also 
extendable to mammalian genomes. 
There is also growing evidence that piRNA-pathway dependent mechanisms may have been critical 
during evolution, in the establishment of developmental robustness. In fact, the piRNA-pathway seems 
to be required for preventing phenotypic variation despite genotypic variation and environmental 
influences (canalization) [55]. The Hsp90 protein was previously described as a capacitator [56] being 
able to prevent phenotypic variation by suppressing the mutagenic activity of transposons [57]. 
Interestingly, it was shown in Drosophila that a protein complex composed of Hsp90, Piwi and Hop, is 
involved in canalization, probably through phosphorylation regulation of the Piwi protein by Hsp90 
and Hop [55]. Therefore, it is possible that the Piwi-piRNA pathway will mediate canalization by both 
suppressing the generation of new genotypes and epigenetically silencing the expression of existing 
genetic variants [55]. 
The piRNAs, contrary to miRNAs, are less conserved through the eukaryotic lineage. This 
difference has been explained by the possible co-evolvement of miRNA with their RNA targets which 
have created sequence divergence constraints. There are increasing examples that piRNAs play roles in 
somatic cells regulating protein encoding genes. It is possible that piRNAs are more likely to be 
involved in epigenetic regulation rather than post-transcriptional regulation [58]. These puzzling facts 
suggest that our knowledge of the mechanistic relationships between piRNAs and the regulatory 
mechanisms based on regulatory proteins is far from being understood. On the other hand, the initial 
evidence that piRNAs may be involved in epigenetic regulation in tumorigenesis [59,60] requires 
additional attention. 
The role of piRNAs in protecting genomes against parasitic nucleic acids seems to have developed 
early in evolution since ciliates present a mechanism that resembles that of piRNAs. Ciliates are single 
celled organisms that present a polyploid macronucleus that guarantees the vegetative growth of cells 
(the somatic nucleus) and the diploid micronucleus that is only active during sexual conjugation and 
constitutes the germline [61]. After conjugation the zygotic macronucleus differentiates from the 
micronucleus by undergoing an extensive developmentally programmed genome reorganization [62]. 
This reorganization involves chromosome fragmentation and elimination of germline limited 
sequences (internal eliminated sequences (IES), transposons and other repeated sequences) according 
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to the pre-existing rearrangements of the maternal somatic genome. This seems to rely on a global 
comparison of the germline and somatic genomes and a genomic subtraction between meiosis-specific, 
germline scnRNAs (small RNAs that resemble piRNAs) and longer non-coding transcripts from the 
somatic genome (for review, see [63]). This mechanism that parallels the patterns of heterochromatin 
formation in other eukaryotes allows the maintenance of an epigenetic memory of rearrangement 
patterns across sexual generations and establishes, in an ancestral unicellular organism, a relationship 
between piRNAs and development. The ancestrality of the piRNAs and the fact that they have been 
placed in developmental frameworks being protagonists in the establishment of developmental 
robustness strongly supports the view that they have been critical factors in eukaryotic evolution. 
2. Long Noncoding RNAs 
It is now clear that the mammalian genome produces a large transcriptome of long noncoding RNA 
(lncRNA, defined as RNA >100 nucleotides in length). The number of gene members integrating this 
class of ncRNAs is still under debate and ranges from 10,000 to >200,000 [64]. 
The lncRNAs can be transcribed from intergenic regions, promoter regions or be interleaved, 
overlapping or antisense to annotated protein-coding genes [44]. There is also growing evidence that 
lncRNAs molecules might be produced by transcriptional active pseudogenes [65]. Although the 
majority of lncRNAs are transcribed from the nuclear genome, recently it was found that some can be 
generated from mitochondrial genomes [66]. Like coding genes, lncRNAs undergo post-transcriptional 
processing, including 5’capping, alternative splicing, RNA editing, and polyadenylation [67,68]. 
The referred transcriptional origins have been used to establish classification classes for lncRNA, as 
for example promoter-associated long RNAs (lpaRNAs) [68], natural antisense transcripts (NATs) or 
opposite-strand transcripts [69], large intervening noncoding RNA (lincRNA) [70], and enhancer 
associated RNAs (eRNA) [71,72]. However, other criteria should probably be used since frequently 
one lncRNA molecule can be associated with more than one class. 
Mammalian genomes encode a large number of natural antisense transcripts (NATs) [64,73]. For 
instance, the FANTOM-3 mouse transcriptome sequencing consortium identified natural antisense 
transcripts for more than 70% of the transcription units, the majority of which represent  
non-protein-coding RNAs [73].  
NATs have been defined as endogenous RNA molecules at least partially complementary to 
transcripts of known function [74]. NATs can be transcribed from the opposite strand at the same 
genomic locus of their sense counterparts and will present perfect sequence complementarity being 
designated by cis-NATs. On the other hand those transcribed from different genomic loci may have 
imperfect sequence complementarity and are named trans-NATs [75]. Sense and antisense RNA pairs 
can present different relative orientations and variable overlapping regions. For example, they can 
overlap by their 5' regions (5' to 5'), by their 3' regions (3' to 3'), or fully-overlap (one gene included 
within the region of the other) [76]. Antisense RNAs have a tendency to have lost introns and typically 
show lower abundance compared with sense transcripts [77]. 
Studies performed in various organisms have suggested that NATs can participate in a broad range 
of regulatory events that will be discussed later. 
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3. The Emerging Roles of lncRNAS and miRNAs 
3.1. LncRNAs: Implications in Different Levels of Gene Expression Regulation and Differentiation 
LncRNAs have emerged as pivotal molecules for the regulation of gene expression [76]. These 
transcripts are biologically relevant as supported by their cell-specific expression pattern [78], 
subcellular distribution [79], developmental regulation and possible association with human diseases. 
LncRNAs encompass a wide variety of functions which include almost all levels of gene expression 
regulation, ranging from epigenetic to translational regulation, including transcriptional and  
post-transcriptional control. The main functions of lncRNAs are summarized below.  
3.1.1. Epigenetic Regulation 
lncRNAs modulate chromatin through the specific recruitment of histone and chromatin modifying 
complexes on one hand and by the recruitment of transcription factors on the other hand. X 
chromosome inactivation (XCI) is the classic example of the former type of regulation and is caused 
by the lncRNA “Xist” which physically associates with the Polycomb repressive complex 2 (PRC2) 
recruiting it to the X chromosome ultimately leading to its inactivation [80]. More precisely, it is a  
1.6-kb ncRNA (RepA) within Xist that targets PRC2. Depletion of RepA abolishes full-length Xist 
induction and trimethylation on lysine 27 of histone H3 of the X (thus abolishing X inactivation). In 
addition it was demonstrated that PRC2 deficiency compromises Xist up-regulation [80]. A similar 
process to XCI is genomic imprinting, an epigenetic event in which genes are expressed from the allele 
of only one parent. One of the first lncRNAs to be identified was H19, which is reciprocally imprinted 
with insulin-like growth factor 2 (Igf2). Even though this lncRNA is highly expressed, its deletion has 
no phenotype and, in fact, recently it has been proposed to function as a microRNA precursor [81]. 
Other lncRNAs (i.e., Air, Kcnq1ot1, HOTAIR) can control chromatin states in cis and/or  
in trans, thereby regulating gene expression through the association with chromatin-modifying  
complexes [82,83]. Specifically, HOTAIR is a trans-acting lncRNA that serves as a scaffold for two 
histone modification complexes: it binds both to polycomb repressive complex 2 (PRC2) and to LSD1 
(in complex with CoREST/REST). This coordinates targeting of PCR2 and LSD1 to chromatin for 
coupled histone H3 at lysine 27 methylation and lysine 4 demethylation leading to subsequent gene 
silencing [84]. Also, in the plant Arabidopsis it was demonstrated that environmental conditions, such 
as cold, are able to induce the transcription of related NATs (i.e., COOLAIR) that are involved in the 
silencing of a flower repressor locus designated by flowering locus c (FLC) [85]. More recently it was 
discovered that a lncRNA, named COLDAIR, that differs from COOLAIR by the fact that it is 
transcribed in the sense direction relative to FLC mRNA transcription, interacts directly with PRC2 
and targets it to FLC, establishing an epigenetic memory [86]. Interestingly, winter cold triggers the 
methylation of H3 at FLC and it was shown that COLDAIR is induced by cold, demonstrating that 
lncRNas participate in the integration of signals from the environment to cell signaling pathways. 
Other trans-acting lncRNAs have different functions some of which remain incompletely defined. 
For example, the p21-associated ncRNA DNA damage-activated (PANDA) lncRNA is induced upon 
DNA damage in a p53-dependent manner and it interacts with the transcription factor NF-YA to limit 
expression of pro-apoptotic genes [87]. Mistral is another example of an lncRNA that acts on the 
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recruitment of the transcription factor MLL1 thereby activating Hoxa6 and Hoxa7 expression and 
subsequent stem cell differentiation [88]. 
Another group of lncRNAs that play a role in mammalian genomes are the long intergenic  
non-coding RNAs (lincRNAs) that range in size from ~300 nucleotides to several thousands and that, 
in humans, have been estimated to be around 3300, although a more correct number may be closer to 
4500 [89]. This group of transcripts is heterogeneous but show significant evolutionary conservation 
relative to neutral sequences [70], which support the idea that they have important functions. In fact, it 
has been described that some groups of lincRNAs present expression patterns that correlate with those 
observed for protein-coding genes involved in cellular processes as diverse as cell-cycle regulation, 
innate immunity responses, and stem cell pluripotency [70,90]. In agreement, a reference catalog of 
8195 human lincRNAs based on integratingRNA-seq data from 24 tissues and cell types showed that 
lincRNAs are expressed in a more tissue-specific manner than protein-coding genes [91]. By using  
co-immunoprecipitation and RNAi approaches it was also demonstrated that lincRNAs are associated 
with chromatin-modifying complexes to specific genomic loci to regulate gene expression [89]. The 
capacity to bind chromatin-modifying proteins or transcription factors, as exemplified, in combination 
with the abundance of lncRNAs suggests that lncRNAs may be part of a broad epigenetic regulatory 
network (reviewed in [92,93]). 
3.1.2. Transcriptional Regulation 
The discovery and characterization of several ncRNAs that are able to associate with promoters 
(promoter associated RNAs—paRNA) is also changing the traditional view of how genes encoding 
proteins are regulated at the transcriptional level. Promoter associated RNAs paRNAs are transcribed 
approximately from the start of or within the promoter, and include long, short and tiny RNA 
molecules (for review [49]). The long paRNAs were found at a single-gene level and were also 
associated with the modification of DNA methylation and demethylation patterns [94], inhibition of 
transposition expression in Saccharomyces cerevisiae [95] and gene expression in humans [96].  
Interestingly, long (antisense) paRNAs have the potential to form double stranded molecules that 
can be processed into endo-siRNAs, and that, due to their sequence complementarity to that of a 
promoter, are able to induce transcriptional gene silencing [97–99] or activation [100–102] in a similar 
way to short paRNAs [49]. This picture is far from being complete since an increasing amount of 
experimental data are supporting the idea that enhancers can be transcribed and the resulting  
enhancer-non coding transcripts (eRNAs) may, in some cases, have functional roles, rather than 
represent mere transcriptional noise (for review see [103,104]). 
On the other hand, lncRNAs can modulate the function of transcription factors by acting as  
co-regulators, modulators of transcription factors activity or by regulating the association and activity 
of co-regulators, among others. The ncRNA Evf-2, for example, functions as a co-activator for the 
homeobox transcription factor Dlx2, which plays important roles in forebrain development and 
neurogenesis [105]. Local ncRNAs can also recruit transcriptional factors and co-activating molecules 
to regulate adjacent protein-coding gene expression. The RNA binding protein TLS, binds to and 
inhibits the CREB binding protein (CCND1) and p300 histone acetyltransferase activities on a 
repressed gene target, cyclin D1. The recruitment of TLS to the promoter of cyclin D1 is directed by 
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single stranded, low copy number lncRNA transcripts tethered to 5' regulatory regions of CCND1 in 
response to DNA damage signals [106].  
Finally, lncRNAs also regulate the basal transcription machinery by targeting transcription factors 
required for the RNAP II transcription of all genes [107]. These general factors include components of 
the initiation complex that assemble on promoters or are involved in transcription elongation. An 
example of lncRNA-mediated regulation of basal transcription is the formation of a stable RNA-DNA 
triplex within the major promoter of the dihydrofolate reductase (DHFR) by an lncRNA that is 
transcribed from an upstream minor promoter of the DHFR gene. This complex prevents the binding 
of the transcriptional co-factor TFIIB [96].  
3.1.3. Post-Transcriptional Regulation  
LncRNAs can act on splicing, on mRNA stability and translation. It has been shown that lnc 
antisense RNA may bind to the sense RNA, masking the splice sites and thereby changing the balances 
between splice variants. Thyroid hormone receptor alpha gene (TRα) is an example where the 
antisense transcript RevErbAα influences splicing of TRα1 and TRα2 mRNAs [108]. Recently, it was 
discovered that a new class of sno-lncRNAs, whose ends correspond to positions of intronic snoRNA, 
are able to interact with the splicing factor Fox2 and alter splicing patterns [109]. The authors also 
showed that some of these sno-lncRNAs map to a genomic region that is deleted in the patients 
presenting Prader-Willi syndrome, strongly suggesting an association of these sno-lncRNAs with the 
disease. LncRNAs can also recruit proteins to mRNA to promote its degradation or stabilization. 
There’s evidence for lncRNA binding to sequences present in the 3' UTR of specific mRNAs, thus 
creating a recognition site for Staufen, a protein that binds double-stranded mRNA and induces its 
decay [110]. By contrast, the lncRNA TINCR (terminal differentiation-induced ncRNA) also interacts 
with Staufen 1 but the complex between TINCR-STAU1 seems to mediate stabilization of mRNAs 
encoding differentiation factors such as Keratin 80 [111]. TINCR-mRNA interaction occurs through a 
motif of 25 nt that is abundantly present in target interacting mRNAs [111]. Another example is that of 
the mRNA of BACE1, a β-secretase responsible for β-amyloid production, that is stabilized and 
protected from RNase cleavage by base pairing of its antisense (BACE1-AS) [112]. Therefore, 
different lncRNAs are able to differentially regulate factors involved in mRNA stability regulation. 
Translational regulation is yet another proposed function for lncRNAs. Such is the case of the 
antisense for PU.1 mRNA. PU.1 mRNA translation is inhibited by a noncoding antisense transcript, 
which is a polyadenylated RNA with a lower concentration but a half-life longer than the sense PU.1 
transcript [113]. On the other hand the lncRNA Uchl1, shuttles from the nucleus to the cytoplasm 
under the control of the mTOR pathway and is involved in the translation up-regulation of the 
ubiquitin carboxy terminal hydrolase L1 (UCHL1) mRNA by promoting its association with 
polysomes [114]. Interestingly, the UCHL1 is a specific neuronal protein involved in rampamycin 
neuroprotective function and more generally in cellular stress response, that has been associated with 
neurodegenerative diseases. The various referred examples clearly show that lncRNAs present a vast 
repertoire of strategies to post-transcriptionally regulate protein encoding genes and different 
molecules are able to differentially modulate a specific regulatory molecule or pathway. 
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3.1.4. Modulation of mRNA Nuclear Trafficking and Control of Nuclear Compartmentalization 
NRON is a non-coding repressor of nuclear factor of the activated T cells (NFAT), which interacts 
with multiple proteins including members of the importin-beta superfamily and likely functions as a 
specific regulator of NFAT nuclear trafficking [115]. 
The lncRNA nuclear-enriched autosomal transcript 1 (NEAT1), and abundant 4 kb ncRNA, is 
retained in nuclei foci that are coincident with “paraspeckles” [79]. It has been demonstrated that it 
contributes to the formation of these dynamic structures of the interchromatin space that are implicated 
in mRNA retention [79]. 
3.1.5. Formation of Endogenous siRNA 
It has been described that NATs can originate siRNAs that will be involved in mRNA  
down-regulation. This mechanism requires the formation of a sense:anti-sense pair of transcripts that 
are then processed into siRNAs. This pair can be originated directly from the same loci (cis-NATs) or 
from different loci (trans-NATs). Interestingly, it was observed that certain trans-NATs are produced 
from pseudogene transcription. For example, in rice, a small number of pseudogenes are transcribed 
and processed into siRNAs, after pairing with the coding gene or a paralogous pseudogene  
transcript [116]. A similar observation was reported in mammals where pseudogene transcripts can be 
processed into small interfering RNAs (siRNA) with the ability to repress gene expression in mouse 
oocytes [117,118]. Therefore, NATs play their gene expression regulatory role through a mechanism 
equivalent to that of miRNAs and siRNAs (see Figure 1). Until recently, pseudogenes were envisaged 
only as copies of protein-coding genes that have lost the ability to produce functional proteins 
therefore constituting junk DNA in genomes [119]. Pseudogenes can be created by diverse processes, 
including: (1) spontaneous mutations, preventing transcription of the gene, or translation of the  
protein [120]; (2) duplication, in which pseudogenes are originated via tandem duplication or uneven 
crossing-over leading to the loss of promoters or enhancers or the appearance of crippling mutations 
such as frame shifts or premature stop codons [119]; and (3) retro-transposition, the mRNA transcript 
being reverse-transcribed and integrated into the genome at a new location originating retro-transposed 
or processed pseudogenes [121,122]. Therefore, their origin directly makes them prone to participate 
in post-transcriptional regulatory mechanisms promoted by lncRNAs. These observations started to 
change the vision that pseudogenes are mere junk in the genomes of organisms, and suggested that 
they can play important biological roles. In agreement with this hypothesis is the fact that the 
transcription of NATs is generally regulated in a tissue-specific manner and varying sense/antisense 
ratios are found [123]. 
It is evident that the critical roles of lncRNAs at different levels of gene expression regulation will 
largely contribute to establish differential profiles of gene expression required for development [124–127]. 
This is supported by the observation that lncRNAs such as Xist [128], TUG1 [129], PINC [130], and 
HOTAIR [131] have important roles in development. Moreover, Dinger et al. [90] using a microarray 
to examine the expression profiles of mouse embryonic stem cells differentiating as embryoid bodies 
over a 16 day time course have identified 945 ncRNAs, of which 174 were differentially expressed, 
many correlating with pluripotency or specific differentiation events [90]. Accordingly, it was also 
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observed that the expression of some lincRNAs is increased in induced pluripotent stem cells (iPSCs) 
in comparison to those found in stem cells. This suggests that their activation may promote the 
emergence of iPSCs. It was also demonstrated that one of this lincRNA (lincRNARoR) modulates the 
reprogramming process leading to pluripotent stem cells [132].  
Figure 1. Gene silencing: mRNA post-transcriptional regulation by lncRNA and miRNA. 
lncRNAs can be transcribed as natural antisense transcripts, from the same loci (cis-NAT, 
the same gene is transcribed in both directions) or from a different loci (trans-NAT, for 
example from a pseudogene). These NATs transcripts can pair with the coding transcripts, 
originating dsRNA molecules that will activate the siRNA machinery leading to mRNA 
degradation. miRNAs are also complementary of coding mRNAs and can pair with a 
perfect match leading to the activation of the siRNA machinery or they can pair with gaps 
leading to translation interference. 
 
Spermatogenesis is a very complex developmental process that requires precise microtubule 
cytoskeleton remodeling, creating complex microtubule structures such as the manchette and the 
flagellum of the sperm [133]. During this process it was observed that the gene encoding TBCA, a 
protein that interacts with -tubulin and is involved in the folding and dimerization of new tubulin 
heterodimers (the building blocks of microtubules) is regulated by a Tbca pseudogene that is 
transcribed in both directions [134]. The Tbca pseudogene is down-regulated leading to the increase of 
the Tbca mRNA, during testis maturation suggesting that this Tbca lncRNA is required for the 
undifferentiated state of spermatids. Similarly, the gene encoding the nitric oxide synthase protein 
(NOS2A) is transcribed into a noncoding RNA containing a region of significant antisense homology 
with the NOS2A mRNA. As in the case of Tbca lncRNA, the expression patterns of the anti-NOS2A 
RNA and the NOS2A mRNA exhibit opposite changes in undifferentiated human embryonic stem 
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cells (hESCs) and in hESCs induced to differentiate into neurogenic precursors [74]. In conclusion, 
lncRNAs are clearly required to regulate programs of differentiation during development and seem to 
be generally associated with the undifferentiated states, repressing critical target genes whose 
expression is crucial for the cells to reach their fate. 
3.2. miRNAs as Critical Regulators of Target Degradation and Translation  
miRNAs act as sequence-specificity guides for the RNAi machinery to mediate repression of target 
gene expression. First identified as regulators of larval development in nematodes [19], miRNAs are 
now known to serve key roles in the regulation of almost every important cellular process in all 
multicellular eukaryotes. These include cell development, proliferation, differentiation, apoptosis and 
oncogenic transformation [135]. The genome of human cells encodes over 1000 miRNA species that 
regulate 60% of all protein-coding genes [32]. Most mRNA targets contain multiple miRNA binding 
sites, and each miRNA can regulate multiple genes. Therefore, the deregulation of miRNA levels 
might perturb the expression of many genes, thereby playing a key role in the occurrence of diseases 
(see below). 
It is still unclear whether miRNAs act mainly at the mRNA translational or transcriptional levels. 
The miRNA repression, at the level of transcriptional inhibition, can occur as a consequence of mRNA 
decay, direct mRNA cleavage or through miRNA-mediated chromatin reorganization. Decay of 
targeted mRNA occurs without direct cleavage at the binding site. Unlike in translational inhibition 
where only a slight protein decrease can be obtained, protein level reductions greater than 33% indicate 
that mRNA decay is the major component of miRNA-driven silencing [136]. miRNA-mediated mRNA 
decay can occur via deadenylation, decapping or 5' to 3' degradation of the mRNA [137]. Dicer1, 
Ago1 and Ago2 were shown to be required for the rapid decay of mRNA containing AU-rich elements 
(AREs) in the 3' UTR of tumor necrosis factor-alpha suggesting that miRNA targeting of ARE is 
essential to mediate mRNA degradation [137]. It was also shown that upon GW182 interaction with 
AGO1, there is recruitment of deadenylases and decapping enzymes, leading to mRNA  
degradation [138]. The mRNA cleavage, another miRNA transcription repressive mechanism that is 
rare in animals, but frequent in plants, normally occurs when there is full complementarity between the 
miRNA and its mRNA target [139]. miRNAs also have the capacity to reorganize chromatin by 
increasing methylation of the targeted mRNA promoters thereby inhibiting their expression [140]. 
Finally, the repressed mRNAs, Ago proteins and miRNAs are frequently accumulated in processing 
bodies (P-bodies), which are cytoplasmic structures enriched in the mRNA degradation machinery but 
where the translational machinery is normally absent [141]. 
The second major mechanism of miRNAs activity includes repression of translation initiation 
and/or elongation, premature termination and nascent polypeptide degradation. Inhibition of translation 
initiation can occur at the level of cap-40S association or via 40S-AUG-60S association. Endogenous 
let-7 micro-ribonucleoproteins (miRNPs) or the tethering of Ago proteins to reporter mRNAs in 
human cells inhibit m(7)G-cap-dependent translation initiation, suggesting that miRNPs interfere with 
the recognition of the cap [142]. The cap-binding protein eukaryotic initiation factor 4E has in fact 
been proposed as a molecular target of miRNA function [143]. Ago2 represses the initiation of mRNA 
translation by directly binding to the m(7)G-cap of mRNA targets, thus likely precluding the 
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recruitment of eIF4E [144]. Another Ago1 was shown to interact with GW182, this interaction being 
essential for miRNA-mediated inhibition of translation [145]. It was also shown that miRNA-repressed 
mRNAs contain 40S but not 60S components suggesting that miRNAs repress translation initiation by 
preventing the 60S subunit from joining to miRNA-targeted mRNAs [146]. It has also been reported 
that some miRNAs can inhibit translation initiation by inducing the formation of dense miRNPs 
(pseudo-polysomes) [147]. The fact that various studies showed repressed mRNA targets to be 
associated with polyribosomes seems to indicate that miRNAs can also repress translation at the 
elongation step [148–150]. Silencing by miRNAs can also occur before completion of the nascent 
polypeptide chain causing a decrease in translational read through at a stop codon, with ribosomes on 
repressed mRNAs dissociating more rapidly after a block of initiation of translation, than those of control 
mRNAs [149]. These observations pinpoint a role for miRNAs in ribosome drop-off-mediated repression.  
Intriguingly, there is also evidence for transcriptional [100] and translational [151] activation by 
miRNAs. The miRNA-373 was shown to induce expression of genes with complementary promoter 
sequences [100]. miRNA-10a can bind to the 5' UTR of ribosomal protein mRNAs and enhances their 
translation [152]. Further, a growing series of studies has demonstrated that miRNAs and their 
associated complexes (microRNPs) elicit alternate functions that enable stimulation of gene expression 
in addition to their assigned repressive roles [151,153]. 
While the global importance of miRNAs is clearly illustrated by the developmental failure of  
Dicer-deficient embryonic stem cells (in vitro) and embryos (in vivo) [154], unique spatial and 
temporal expression patterns in distinct hematopoietic and neuronal lineages are clearly suggestive of 
multiple roles for miRNA in hematopoiesis, immune responses and neurological differentiation. The 
specific profiling of hPSCs by microarray and sequencing methods has allowed the identification of 
miRNAS that have potential roles in differentiation and development (reviewed in [155]). Several 
miRNA families, including the human (hsa)-miR-302, hsa-miR-106, hsa-miR-372, hsa-miR-17,  
hsa-miR-520, hsa-miR-195 and hsa-miR-200 families [155] were up-regulated specifically in hPSCs 
compared to mature differentiated cell types. Interestingly, the “seed” sequences (short sequence at 
nucleotides 2-8 on the 5' end of the miRNA that binds to the 3' UTRs of their target mRNAs) for most 
of these miRNAs are closely related, suggesting that these miRNA families may share mRNA targets. 
Thus, their regulatory functions might help maintain the unique characteristics of PSCs. Contrary to 
the miRNA families the hsa let-7 family [155] is expressed at significantly lower levels in hPSCs than 
in differentiated cells. The miRNA-dependent post-transcriptional gene regulation is also crucial for 
neural and immune cell development. Early evidence for miRNA function in the nervous system 
development came partly from knockout mutations of the miRNA processing genes present in the 
miRNA pathway. Pioneering studies of nervous system development using maternal-zygotic mutants 
of zebrafish dicer revealed gross morphological defects specifically in early brain patterning and 
morphogenesis [156]. Detailed studies of later stages in neural development have begun to suggest a 
more extensive contribution of miRNAs in the formation of synaptic connections, circuit maturation, 
and the activity-driven plasticity of these connections. For example, the mRNA processing enzyme 
DGCR8 mutant mice exhibited abnormalities in synaptic connectivity due to a reduction in the number 
and size of dendritic spines, reduced synaptic complexity, impaired synaptic transmission, and altered 
short-term plasticity [157].  
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In the immune system, miRNAs mediate the regulation of T cell development and function, as 
confirmed by the observation of defective thymic and peripheric T cell subsets in Dicer deficient  
mice [158,159]. 
Individual miRNAs play different roles at distinct developmental stages. For example, miR-125b 
and miR-132 regulate dendritic spine development. More specifically, miR-125b and miR-132 (as well 
as several other miRNA) are associated with fragile X mental retardation protein (FMRP) in mouse 
brain. The miR-125b overexpression results in longer, thinner processes of hippocampal neurons. 
FMRP knockdown is shown to ameliorate the effect of overexpressed miR-125b and miR-132 on spine 
morphology. It has been proposed that miR-125b negatively regulates its target, NR2A, along with 
FMRP and AGO1 [160]. 
Focusing on T cells, miRNA expression patterns vary among stages of development and T cell 
subsets, which indicate that these molecules may contribute to the identity of the cell subsets or their 
functional state [161]. Consistent with this, recent reports have demonstrated that various miRNAs, 
namely miR-101, miR-150, miR-155, miR181a, miR-29a, miR-146a and miR-326, are expressed in 
particular T cell subsets and regulate several aspects of their differentiation and function [162–164] . 
Like lncRNAs, miRNAs are required to regulate differentiation programs during development. 
However, they are associated with both undifferentiated and differentiated states repressing target 
genes involved in maintaining those programs. 
4. ncRNAs Active Players in Cancer and Other Human Diseases 
The deregulation of gene expression networks, responsible for normal cellular identity, growth and 
differentiation leads to cancer. The large majority of genome-wide association studies (GWAS) 
identify cancer risk loci outside of protein-coding regions. Of 301 single-nucleotide polymorphisms 
(SNPs) currently linked to cancer, only 12 (3.3%) change the protein amino-acid sequence. Most are 
located in the introns of protein-coding genes (40%) or intergenic regions (44%), raising the question 
of the function of these noncoding loci and their role in cancer development [165]. These facts, 
associated with the observations that miRNA and lncRNAs are involved in programs of differentiation 
and development soon raise the hypothesis that alterations in their profiles of expression could be 
correlated with cancer development. In the last years, numerous evidences have confirmed this 
hypothesis since miRNas and long ncRNAs, that present tissue-specific expression, were found to be 
deregulated in distinct types of cancers. For example, data coming from microarray expression from a 
wide range of distinct cancers showed that alterations in miRNAs are almost always present in the 
analyzed tumors [166]. More specifically, overexpression of miR-155 was reported in hematopoietic 
cancers, breast, lung and colon cancer [167], whereas miR-21 was found to be overexpressed in 
glioblastoma and to have antiapoptotic properties [168,169]. Also, transgenic mice overexpressing 
miR-17-92 developed lymphoproliferative disorders [170] and retroviral overexpression of the cluster 
accelerated lymphoma formation. The miR-17-92 cluster was also found to be overexpressed in lung, 
colon and gastric cancer [171]. Like miRNAs, lncRNAs have also been associated with cancer 
development. For example, the lncRNA MALAT1 is up-regulated in several cancer types and its 
overexpression has been linked to an increase in cell proliferation and migration in lung and colorectal 
cancer cells [165]. These phenotypes are probably related to the role of MALAT1 in controlling 
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alternative splicing of pre-mRNAs [172]. However, this relationship is probably too simplistic since a 
more recent study indicates that MALAT1 may also have a role in the regulation of gene expression, 
different from alternative splicing, in lung metastasis [173]. 
Many studies have also shown that miRNA and LncRNAs themselves can function as tumor 
suppressor genes or oncogenes, [174–176]. Several studies found that the tumor suppressor p53 
transcriptionally regulates the three gene members of the miR-34 family. On the other hand, the  
miR-34 activation resembles p53 activity, including induction of cell-cycle arrest and promotion of 
apoptosis, and loss of miR-34 can impair p53-mediated apoptosis [177]. However, the interaction 
between p53 and miR-34 is much more complex since mice possessing the combined loss of all three 
miR-34 members are viable and fertile, do not display morphological defects and are not prone to 
spontaneous tumor formation [178]. 
Similarly to miRNAs, some lincRNAs are transcriptional targets of p53 like the lincRNA-p21 that 
plays a role as a transcriptional repressor in the p53 pathway by triggering apoptosis. The lincRNA-p21 
binds to hnRNP-K that allows for the correct localization of hnRNP-K, probably by influencing their 
target preference, and therefore the transcriptional repression of p53-regulated genes [179]. The precise 
mechanism by which lincRNA-p21 contributes to repression at specific loci remains to be defined. 
Although most of the mechanisms that implicate lncRNA in cancer biology are uncovered, the 
growing available data show that they are probably linked for example to chromatin remodeling. For 
example lncRNAs that are known to be involved in the recruitment of epigenetic modifiers to specific 
loci such as ANRIL, XIST, HOTAIR and KCNQ1OT1 were observed to have modified expression in 
a variety of cancers [176]. Also the lncRNA named TERRA, which binds telomerase, inhibiting its 
activity in vitro [180] is downregulated in many cancer cells which may be related to the longevity of 
cancer cells.  
The broad functional classes of genes and regulatory pathways that involve ncRNA participation 
clearly justifies that the deregulation of their biogenesis and roles could are not restricted to cancer 
development (Figure 2). Perturbations in the biogenesis and actions of ncRNAs have also been 
associated with diverse neurodegenerative diseases such as Huntington’s disease [181], Alzheimer [182] 
and Parkinson [183]. Moreover, recent studies have shown that miRNAs have unique expression 
profiles in cells of the innate and adaptive immune systems, suggesting that these molecules are 
important regulators of immune cell functions (reviewed in [184]). In fact, the role of miRNAs have 
been linked to autoimmune disorders (e.g., systemic lupus erythematosus, rheumatoid arthritis, 
multiple sclerosis, inflammatory bowel disease, psoriasis) and inflammatory pathologies of distinct 
organ (e.g., atherosclerosis, osteoarthritis, atopic eczema) and/or systemic locations like allergy. 
Chromatin remodeling by lncRNA is not exclusively related with cancer but is also linked to other 
diseases like facioscapulohumeral muscular dystrophy (FSHD) [185], lethal lung developmental 
disorder [186] and the HELLP syndrome, a pregnancy-associated disease [187]. 
The presented examples directly implicate long ncRNA and miRNAs in cancer biology and other 
human diseases and indicate that a complex interplay between their biogenesis pathways, their 
regulatory mechanisms and their targets should be seriously taken into consideration not only in cancer 
research but in other human pathologies and also in the definition of future strategies of diagnostics 
and therapeutics.  
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Figure 2. Diagram of functional relationships among lncRNAs, siRNAs, miRNas and 
piRNAs. This “venn diagram” depicts the specific function of each RNA molecule (inside 
each circle) as well as the shared functions (overlapping areas). Some of the disorders 
caused by deregulation in the expression patterns of these RNA molecules are indicated 
outside the circles. 
 
5. Concluding Remarks 
In the last years we have witnessed an unprecedented discovery of numerous functions of  
non-coding RNAs in eukaryotic cells ranging from gene expression regulation to genome imprinting 
roles that were previously attributed to proteins.  
This means that proteins are likely to cooperate with ncRNAs to control gene expression at different 
levels of regulation. They cooperate in the regulation of the transcription of genes encoding proteins, to 
process and maturate their transcripts and finally to regulate their mRNA stability and translation. 
Moreover, upstream of these regulatory steps, cooperation will also be required for altering DNA 
methylation profiles and the remodeling of chromatin contributing to epigenetic regulation. This means 
that complex networks between proteins and RNAs have been established during the course of 
evolution. We can envisage and speculate that due to their biochemical nature and biogenesis, ncRNAs 
will contribute to speed-up, make more flexible, transform and ultimately make more accurate the 
regulatory pathways conducted by regulatory proteins, pushing gene expression regulation to a new 
level. It is predictable that this complex regulatory web will have several hubs that will be composed 
of ncRNAs and proteins or alternatively only proteins or ncRNAs, which will also allow a rapid and 
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better integration of different environmental signals. Although, the field of ncRNAs has been growing 
fast we are still far from understanding the complexity and the mechanisms underlying the 
establishment of the regulatory networks between RNAs and proteins.  
From the evolutionary point of view it seems that the “invention” of proteins like telomerase was a 
critical step in the establishment of accurate spatial and temporal regulatory processes which probably 
allowed the evolution of eukaryotic complexity and later on, the appearance of multicellularity. In the 
view of an “RNA World hypothesis” it is tempting to speculate that the first RNA activities were to 
maintain the viability and integrity of “cell precursors” defending them from destructive invader 
molecules; these ancestral defense functions of ncRNAs that are still present and operate in “modern 
cells” seem to havebeen extended to mechanisms of gene regulation.  
It should also be pointed out that the close analysis of different classes of ncRNAs (sncRNA and 
lncRNA), and the fact that we can detect biogenesis (see Figure 1) and functional overlaps between 
them (see Figure 2), strongly supports the idea that they could also have close interactions, not only at 
the level of their biogenesis pathways, but also at the functional level. This has been probably missed 
to a certain extent by the fact that they have been essentially separately studied. 
From what has been compiled, the deregulation of biogenesis and functional roles of ncRNAs were, 
as expected at the crossroads of different human pathologies ranging from cancer to neurodegenerative 
and immune diseases. Finally the continued understanding of the molecular mechanisms and signaling 
pathways where ncRNAs participate should offer new insights to define new diagnostic strategies and 
open new avenues for therapies. 
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